Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness.
about
Intratumoral Heterogeneous F-18 Fluorodeoxyglucose Uptake Corresponds with Glucose Transporter-1 and Ki-67 Expression in a Case of Krukenberg Tumor: Localization of Intratumoral Hypermetabolic Focus by Fused PET/MR ImageStrain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility studyMethodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop.Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome predictionCharacterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.Characterizing at-Risk Voxels by Using Perfusion Magnetic Resonance Imaging for Cervical Cancer during Radiotherapy.The prognostic value of PET and PET/CT in cervical cancerPalliative radiotherapy in locally advanced head and neck cancer after failure of induction chemotherapy: comparison of two fractionation schemesPredictive value of modelled tumour control probability based on individual measurements of in vitro radiosensitivity and potential doubling time.Heterogeneous breast tumoroids: An in vitro assay for investigating cellular heterogeneity and drug delivery.Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.Differential level of DSB repair fidelity effected by nuclear protein extracts derived from radiosensitive and radioresistant human tumour cells.Cell survival curve for primary hepatic carcinoma cells and relationship between SF(2) of hepatic carcinoma cells and radiosensitivity.Comparison of predicted and clinical response to radiotherapy: a radiobiology modelling study.Chromosome 6p21.2, 18q21.2 and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy.Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience.Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.The Relative Biological Effect of Spread-Out Bragg Peak Protons in Sensitive and Resistant Tumor Cells
P2860
Q33704453-4DC96336-87DA-4D5A-9118-1D273D248F27Q33814902-CE92246B-7901-4E89-87D6-4BE56B6A1BE9Q34913450-3B184B02-4801-4FE9-94B3-790E610C15B1Q35142265-E3B2118F-073C-4181-BBEF-77E2A790AEC6Q35216099-600E9628-6808-428A-B8C1-F9B6CC763EF5Q36800482-B121A5FB-EC31-4A01-BBAA-F0D4AFB61B74Q36836254-91C4AF45-9242-461C-8A94-B0C6DA4FE02DQ37368979-C811A324-E08F-4EC5-9BFC-6B9CEF05F94CQ40094376-60214CD5-1227-41FF-BCDB-FECD3BEC4FBFQ40196993-D01968F6-D83A-498B-A345-3159A3CDD47EQ40689410-A2CDB95D-A25D-45B4-92B1-392E84F21EE6Q41931896-BDB7840D-5E41-4C76-8203-2DBCBFF849AAQ42134001-94658671-B7DF-42E6-85FA-90A4D4D444CAQ45287715-3C02C229-4967-473D-B287-840ACF19A40AQ45735450-A0F30A54-F24B-4D48-A4C6-CA65C418E0F8Q51384677-D44D3E6F-840E-453E-B71F-E605C63E3022Q53068176-02885ACB-30D7-4DCA-ADEF-501658EAA859Q53359183-51B25738-4262-4342-B5F1-B0EFD95AF769Q57149480-7CE32016-B29D-4206-91B6-A438065BA7A0
P2860
Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Intratumoral heterogeneity as ...... or tumour radioresponsiveness.
@en
Intratumoral heterogeneity as ...... or tumour radioresponsiveness.
@nl
type
label
Intratumoral heterogeneity as ...... or tumour radioresponsiveness.
@en
Intratumoral heterogeneity as ...... or tumour radioresponsiveness.
@nl
prefLabel
Intratumoral heterogeneity as ...... or tumour radioresponsiveness.
@en
Intratumoral heterogeneity as ...... or tumour radioresponsiveness.
@nl
P2093
P1476
Intratumoral heterogeneity as ...... or tumour radioresponsiveness.
@en
P2093
Allalunis-Turner MJ
Britten RA
Pearcey RG
P304
P356
10.1016/0167-8140(96)01719-7
P577
1996-05-01T00:00:00Z